Related Experiment Video

Updated: May 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Endemic mycoses: overlooked causes of community acquired pneumonia

Chadi A Hage1, Kenneth S Knox, Lawrence J Wheat

  • 1Pulmonary-Critical Care and Infectious Diseases, Indiana University and Richard L. Roudebush VA Medical Center, 1481 W. 10th St., 111P-IU, Indianapolis, IN, USA. chage@iupui.edu

Respiratory Medicine
|March 6, 2012
PubMed

Insights

Endemic mycoses like Coccidioidomycosis, Histoplasmosis, and Blastomycosis are often missed causes of community-acquired pneumonia. Early diagnosis and treatment are crucial to prevent severe outcomes from these fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Endemic mycoses are frequently underestimated causes of community-acquired pneumonia (CAP).
  • Delayed diagnosis and treatment of these fungal infections can lead to severe patient outcomes.
  • CAP guidelines often do not adequately address endemic mycoses.

Purpose of the Study:

  • To review the epidemiology, clinical presentations, diagnostic methods, and treatment strategies for three major North American endemic mycoses presenting as CAP.
  • To highlight the importance of recognizing Coccidioidomycosis, Histoplasmosis, and Blastomycosis in the differential diagnosis of CAP.

Main Methods:

  • Literature review focusing on endemic mycoses in North America.
  • Synthesis of information on epidemiology, clinical manifestations, diagnostic approaches, and therapeutic interventions.
  • Analysis of current treatment guidelines and recommendations.

Main Results:

  • Coccidioidomycosis, Histoplasmosis, and Blastomycosis are significant causes of CAP in endemic regions.
  • Distinct epidemiological patterns and clinical presentations characterize each mycosis.
  • Accurate diagnosis relies on a combination of clinical suspicion, imaging, and microbiological or serological testing.
  • Antifungal therapy is the cornerstone of treatment, with specific regimens varying by causative agent and disease severity.

Conclusions:

  • Endemic mycoses represent a critical, yet often overlooked, component of CAP.
  • Increased awareness and timely diagnostic evaluation are essential for improving patient outcomes.
  • Further research and updated clinical guidelines are needed to better integrate the management of endemic mycoses into CAP protocols.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.